Honig S C, Thompson S, Lipshultz L I
Baylor College of Medicine, Houston, Texas.
Curr Opin Obstet Gynecol. 1993 Apr;5(2):245-51.
Evaluation of the male factor in infertility is becoming increasingly important as new diagnostic techniques and therapeutic options become available. Varicoceles are among the most common treatable cause of male infertility. Varicoceles are present in 10% to 20% of all males but are found in as many as 30% to 40% of men who present to an infertility clinic. Of men who have treatment for varicoceles, 50% to 75% will show some improvement in semen quality, and 30% to 40% will initiate a pregnancy. We review some controversial issues related to the diagnosis and treatment of varicoceles. In vitro fertilization, originally developed for the female with irreversible tubal damage, is now being evaluated as a possible therapy for severe male-factor infertility that has failed to respond to routine surgical or medical treatment. In vitro fertilization for the oligospermic male, however, is further complicated by the fact that men with poor sperm production frequently have poorly functioning sperm as well. Consequently, we discuss the value of the sperm penetration assay, with and without enhancement techniques to prospectively evaluate couples entering in vitro fertilization programs. We also discuss the role of strict criteria for determination of sperm morphology and quantitation of leukocytospermia in the evaluation of the infertile male. Finally, evaluation of the predictive value of "failure to fertilize" at in vitro fertilization for future in vitro fertilization success is discussed.
随着新的诊断技术和治疗方法的出现,男性不育因素的评估变得越来越重要。精索静脉曲张是男性不育最常见的可治疗病因之一。在所有男性中,精索静脉曲张的发生率为10%至20%,但在不育门诊就诊的男性中,这一比例高达30%至40%。接受精索静脉曲张治疗的男性中,50%至75%的人精液质量会有所改善,30%至40%的人会成功受孕。我们回顾了一些与精索静脉曲张诊断和治疗相关的争议性问题。体外受精最初是为输卵管不可逆损伤的女性开发的,现在正被评估为治疗对常规手术或药物治疗无反应的严重男性因素不育的一种可能疗法。然而,对于少精子症男性的体外受精,情况更为复杂,因为精子生成不良的男性其精子功能通常也很差。因此,我们讨论了精子穿透试验的价值,包括有无增强技术,以前瞻性评估进入体外受精程序的夫妇。我们还讨论了严格的精子形态学判定标准和白细胞精子症定量在不育男性评估中的作用。最后,讨论了体外受精时“受精失败”对未来体外受精成功的预测价值评估。
Asian J Androl. 2002-12
Curr Opin Obstet Gynecol. 1992-4
Urol Clin North Am. 1987-8
J Reprod Med. 1989-2
Tijdschr Kindergeneeskd. 1986-6
J Assist Reprod Genet. 2002-4
Pediatr Surg Int. 1997-7